Next Article in Journal
A Systematic Review of Candidate Genes for Major Depression
Previous Article in Journal
St. Thomas Modified Cardioplegia Effects on Myoblasts’ Viability and Morphology
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Resolution of Papilledema Following Ventriculoperitoneal Shunt or Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus: A Pilot Study

1
Department of Neurosurgery, Bangabandhu Sheikh Mujib Medical University, Dhaka 1205, Bangladesh
2
Department of Neurosurgery, Azienda Ospedaliera Universitaria Pisana (AOUP), University of Pisa, 56100 Pisa, Italy
3
Department of Neurosurgery, Bangladesh Medical College and University, Dhaka 1205, Bangladesh
*
Author to whom correspondence should be addressed.
Medicina 2022, 58(2), 281; https://doi.org/10.3390/medicina58020281
Submission received: 7 January 2022 / Revised: 7 February 2022 / Accepted: 11 February 2022 / Published: 13 February 2022

Abstract

:
Background and Objectives: Ventriculoperitoneal Shunt (VPS) and Endoscopic Third Ventriculostomy (ETV) are both gold standard procedures to reduce intracranial pressure (ICP) in patients with obstructive hydrocephalus, which often results in papilledema. This comparative study was carried out at the Department of Neurosurgery of Dhaka Medical College and Hospital to compare the efficacy of VPS and ETV in the resolution of papilledema in 18 patients with obstructive hydrocephalus. Materials and Methods: The success of CSF diversion was evaluated by a decrease in retinal nerve fiber layer (RNFL) thickness by optical coherence tomography (OCT) and modified Frisen grading of papilledema at the same time. The statistical analyses were carried out by using paired sample t test and the Spearman’s correlation coefficient test. The level of significance (p value) was set at <0.05. Results: After 7 days, both VPS and ETV were able to reduce RNFL thickness of both eyes with a p value = 0.016 (right eye) and 0.003 (left eye) in group A (VPS) and with a p value <0.001 (both eyes) in group B (ETV). Change of Frisen grading after CSF diversion was not satisfying for both the procedures with p value > 0.05. Further, the inter-group comparison between VPS and ETV showed no difference in decreasing RNFL thickness and modified Frisen grading (p value = 0.56). Conclusion: VPS and ETV procedures both appear very efficient in treating obstructive hydrocephalus, which in turn reduces papilledema in these patients. This paper is preliminary and requires further work.

1. Introduction

Obstructive hydrocephalus is the clinical condition characterized by enlargement of cerebral ventricles and associated symptoms caused by raised intracranial pressure (ICP). The main goal of treatment is to decrease raised ICP, either by ventriculoperitoneal shunt (VPS) or endoscopic third ventriculostomy (ETV) [1,2,3,4]. Endoscopic third ventriculostomy (ETV) and ventriculoperitoneal shunt (VPS) are two surgical methods used for the treatment of obstructive hydrocephalus to create an alternative pathway for CSF to flow out of the ventricles and around the brain (ETV) or in the peritoneum (VPS). Increased ICP in patients with obstructive hydrocephalus can cause various systemic symptoms, as well as neuro-ophthalmic complications. The most common neuro-ophthalmic complications are papilledema and secondary optic atrophy [5,6]. Papilledema is defined as an optic disc swelling secondary to raised intracranial pressure which usually presents bilaterally and may develop within hours to weeks. Papilledema from various causes of IH may develop at any age, in either sex, and in any racial or ethnic group [7]. Several larger neurosurgical series found papilledema in up to 60–80% of patients with cerebral tumors [8]. Classical symptoms include headache, usually worse when awakening, vomiting and blurring of vision. Possible conditions causing high intracranial pressure and papilledema include intracerebral mass lesions, cerebral hemorrhage, head trauma, meningitis, hydrocephalus, spinal cord lesions, impairment of cerebral sinus drainage, anomalies of the cranium, and idiopathic intracranial hypertension (IIH) [7]. Fundus examination shows hyperemia and swelling of the optic disc, blurring of the disc margin, blurring of the peripapillary retinal fiber layer and absence of spontaneous venous pulsations [9]. Brain imaging and even serial brain imaging may not be enough to decide whether the brain is under pressure. In such patients, identifying papilledema and reducing ICP are crucial in the clinical management of patients with obstructive hydrocephalus [10]. There are numerous tests used for the screening of papilledema, and the sensitivity and specificity of each of these objective tests is still being debated. Early diagnosis of papilledema can help in early intervention, thus preventing visual loss, and even death [11,12]. Papilledema can be graded clinically using a modification of Frisen criteria [13]. Funnell et al. [14] reported that patients with papilledema had higher ICP values than patients who did not develop papilledema (10.4 vs. 6.3 mmHg, respectively) and observed that Frisen grade was statistically correlated with ICP values, whereas patients with higher ICP values were more likely to develop papilledema. Optical coherence tomography (OCT) is a non-invasive imaging technique which obtains retinal images closely resembling histological preparations, and is useful in evaluating the peripapillary nerve fiber layer thickness. OCT can detect and quantify diffuse thickening of the retinal nerve fiber layer (RNFL) in eyes with papilledema [15]. Mean RNFL thickness (360° measurement) ranges from 46 to 106 µm in normal eyes [16]. Resolution of the papilledema is commonly thought to be a good clinical indicator of decreased ICP after surgery [17,18]. Although different studies reported different cost-effectiveness, availability of the procedures, complications, revision and both clinical and radiological outcomes between VPS and ETV [19,20,21], at present there is no clear consensus on which procedure is better. For this reason, we performed a comparative prospective study to investigate and compare the effects of VPS and ETV on the resolution of papilledema from raised ICP due to obstructive hydrocephalus and if any differences in RNFL thickness by OCT occurred between two groups. We measured the rate of resolution RNFL thickness by OCT in both VPS and ETV, and reported the regression of papilledema and the effectiveness of the procedures. To the best of our knowledge, few studies in the literature reported an objective estimate of the papilledema due to obstructive hydrocephalus, using an objective measurement of the thickness of the RNFL measured byoptical coherence tomography.

2. Materials and Methods

This prospective comparative study was carried out in the Department of Neurosurgery of Dhaka Medical College and Hospital, Dhaka, Bangladesh (protocol code: ERC-DMC/ECC/2019/390) within the period of June 2018 and June 2020. All 18 patients signed informed consent for this study. Inclusion criteria were patients older than 18 years old having papilledema due to obstructive hydrocephalus from any intracranial lesion, of any age and sex, admitted in hospital. The exclusion criteria were patients’ inability to cooperate with the ophthalmic examination, patients having previous surgery for obstructive hydrocephalus and patients having any other ophthalmic diseases. According to the selected criteria, the study recruited 18 patients (36 eyes) who had papilledema due to raised intracranial pressure from obstructive hydrocephalus. All 18 patients underwent surgery, either VPS or ETV, for obstructive hydrocephalus and were randomly and prospectively divided into due groups: group A (patients underwent VPS) and group B (patients underwent ETV). Retinal nerve fiber layer (RNFL) thickness measurement and modified Frisen grading (Table 1) with color fundal photography were obtained in all patients 3 to 4 h before VPS or ETV surgeries and 7 days postoperatively, then patients with tumors underwent surgery for tumor removal.
The success of the procedures (resolution or subsidence of papilledema = improvement of visual blurring) was assessed via modified Frisen grading by fundoscopy and via RNFL thickness measurement by optical coherence tomography (OCT). OCT is a noninvasive, high-resolution optical imaging technology based on interference between signal from an object under investigation and a local reference signal [22]. These measures were evaluated by a single ophthalmologist. Here, average decrease in RNFL thicknesses and mean grade change for Frisen grading were used for comparison. Improvements of clinical symptoms regarding ICP and decrease in RNFL thickness on OCT resulted in a good surgical outcome. This study was conducted using a super-luminescent diode scan with a center wavelength of 840 nm and an acquisition rate of 27,000 A-scans per second at an axial resolution of 5 μm to measure RNFL thickness. Post-operative CT scans were obtained in all cases to rule out any hemorrhagic complications.

3. Results

Nine patients underwent VPS (Group A) and 9 patients underwent ETV (Group B). The mean ages of patients in Groups A and B were 30.7 ± 10.5 years old (range 18–47 years old) and 33.1 ± 11.2 years old (range 19–50 years old), respectively. Primary pathologies in both groups were 4 cerebellopontine angle (CPA) tumors (2 in group A, 2 in group B), 4 posterior fossa tumors (3 in group A, 1 in group B), 6 aqueductal stenosis (2 in group A, 4 in group B), and 4 pineal tumors (2 in group A, 2 in group B). All the 18 (100%) patients had bilateral papilledema, and headaches, with vomiting in 11 (61.1%) cases, hearing loss in 6 (33.3%), and gait disturbances in 6 (33.3%) cases. Table 2 shows all patient details.
All 18 patient were evaluated by an ophthalmologist before VPS or ETV surgeries and 7 days postoperatively, then 12 out 18 patients (66.7%) underwent surgery for tumor removal. For this reason, follow-up were performed after 7 days. In group A (VPS), mean RNFL thickness was 159.8 ± 59.4 µm preoperatively and 128.4 ± 36.3 µm postoperatively for right eyes, whereas mean RNFL thickness was 189.00 ± 56.6 µm preoperatively and 124.2 ± 27.6 µm postoperatively for left eyes. The mean RNFL thickness in group B (ETV) for right eyes was 158.4 ± 30.7 µm preoperatively and 110.5 ± 27.5 µm postoperatively. For the left eyes, the mean RNFL thickness was 161.1 ± 45.2 µm preoperatively and 99.6 ± 21.6 µm postoperatively. Table 3 shows more details. Decrease in mean RNFL thickness after either VPS or ETV (7 days postoperatively) was statistically significant for both eyes in both groups (VPS and ETV). Table 4 shows more details. No differences were seen on the bilateral nature of the papilledema in both groups based on the tumor location. RNFL thickness usually varies with age, however it seems that obstructive hydrocephalus did not affect RNFL thickness according with age.
In group A (VPS), pre-operative modified Frisen grading of papilledema right eyes were grade 1 in 3 patients, grade 2 in 1 patient, grade 3 in 4 patients, and grade 5 in 1 patient (Table 5). Postoperatively, patients improved regarding Frisen grading: 6 patients were grade 1, 2 patients were grade 2, and only 1 patient had grade 3 papilledema, who started at grade 5. In the same way, pre-operative modified Frisen grading of papilledema in left eyes were grade 1 in 2 patients, grade 2 in 1 patient, grade 3 in 3 patients, grade 4 in 2 patients, and grade 5 in 1 patient. Patients also improved regarding Frisen grading after VPS: 7 patients were grade 1, 1 patient was grade 2, and 1 patient was grade 3. These changes to the severity of papilledema were statistically significant (p value = 0.028) for right eyes and not statistically significant for left eyes (p value = 0.333). Figure 1 shows pre-operative eyes and post-operative eyes fundus and OCT in patient no. 3, who was treated with VPS.
In group B (ETV), pre-operative modified Frisen grading of papilledema right eyes were grade 1 in 1 patient, grade 2 in 2 patients, grade 3 in 5 patients, and grade 4 in 1 patient (Table 6). Post-operatively, 5 patients were grade 1 and 2 patients were grade 2 and 1 patient was grade 3 papilledema. In the same group B (ETV), in the left eyes, pre-operative modified Frisen gradings of papilledema were grade 1 in 1 patient, grade 2 in 3 patients, grade 3 in 2 patients, and grade 4 in 3 patients. Post-operatively, 5 patients were grade 1, 3 patients were grade 2, and 1 patient was grade 3. These changes of papilledema severity were not statistically significant in either the right (p value = 0.13) or left eyes (p value = 1.0). Figure 2 shows pre-operative eyes and post-operative eyes fundus and OCT in patient no. 15, who was treated with ETV.
Mean RNFL thickness differences (for both eyes) between pre-operative and post-operative periods (7 days after shunt surgeries) in Group A (VPS) and Group B (ETV) ere 48.1 ± 41.3 µm and 54.6 ± 28.1 µm, respectively. These differences between pre-operative and post-operative periods in both groups were not statistically significant (p value 0.56). Similarly, mean Frisen grading differences (for both eyes) between pre-operative and post-operative periods in Group A (VPS) (1.53 ± 0.87) and in Group B (ETV) (1.35 ± 1.11) were not statistically significant (p value 0.56).

4. Discussion

All 18 patients (100%) had papilledema and blurring of vision in both eyes at the time of enrolment into the study. The classical triad of raised ICP: headache, vomiting and visual disturbance were ubiquitous to any mode of presentation whether it was acute or chronic. In the present study, there were 4 (22.3%) cases of CPA tumor, 4 (22.3%) cases of posterior fossa tumor, 6 (33.33%) cases of aqueductal stenosis, and 4 (22.3%) cases of pineal tumor.
Chahlavi et al. [23] presented similar data regarding the etiology of adult-onset obstructive hydrocephalus. That study, regarding etiology of obstructive hydrocephalus, showed that space occupying lesions accounted for 58.9% and aqueductal stenosis accounted for 34.3% of obstructive hydrocephalus [23]. In a pre-operative fundoscopy of group A (VPS), Frisen grade 3 papilledema was commonly followed by grade 1 papilledema. After VPS, grade 1 papilledema was most common for both eyes which denotes a decrease in the severity of the papilledema after CSF diversion. Change of grading happened in 6 patients out of 9 in both eyes (66.67%) with a p value of 0.028 for right eye and 0.333 for left eye. On the other hand, pre-operative fundoscopy of group B (ETV) showed Frisen grade 3 and grade 4 papilledema were commonly followed by grade 2 papilledema. After ETV, grade 1 papilledema was common for both eyes, which denotes a decrease in the severity of papilledema after CSF diversion. Change of grading occurred in 5 patients out of 9 in both eyes (55.5%) with a p value of 0.13 for the right eye and 1.0 for the left eye. Rizzo et al. [24] showed CSF shunting resulted in decrement of Frisen papilledema grade by 2.19 ± 0.71 (p < 0.0001). As CSF diversion is supposed to relieve papilledema in obstructive hydrocephalus but may be associated with a transient or permanent absorptive component, it may hinder the complete resolution of raised intracranial pressure.
The absorptive component in the background of obstructive hydrocephalus influenced the grading change in papilledema [24]. The mean pre-operative RNFL thickness in group A for right eyes was 159.8 ± 59.4 µm, while the mean post-operative (7 days after shunt surgeries) RNFL thickness for right eyes was 128.4 ± 36.3 µm. The change in mean RNFL thickness carried a statistically significant level (p-value) of 0.016. In case of left eyes, the mean pre-operative RNFL thickness was 189.0 ± 56.6 µm and the mean post-operative RNFL thickness was 124.2 ± 27.6 µm. The change in mean RNFL thickness carried a statistically significant level (p-value) of 0.003. In contrast, the mean pre-operative RNFL thickness in group B for right eyes was 158.4 ± 30.7 µm, while the mean post-operative RNFL thickness for right eyes was 110.5 ± 27.5 µm. The change in mean RNFL thickness carried a statistically significant value (p-value) < 0.001. In the case of left eyes, the mean pre-operative RNFL thickness was 161.1 ± 45.2 µm and the mean post-operative RNFL thickness was 99.6 ± 21.6 µm. The change in mean RNFL thickness carried a statistically significant level (p-value) of 0.001. Koktekir et al. [25] reported a pre-operative RNFL thickness of 244.5 ± 53.4 microns and a post-operative RNFL thickness of 147.5 ± 54.1 microns following VP shunt surgery. They also showed a pre-operative RNFL thickness of 259.7 ± 35.8 microns and a post-operative RNFL thickness of 158.3 ± 21.1 microns in the case of ETV [25]. As the resolution of the papilledema is a good clinical indicator of decreased ICP after surgery, the existence of papilledema in the follow-up period is more predictive than radiological findings regarding failure of the surgical procedure [25,26,27,28,29]. In 2017, Alfonso et al. [30] proposed the use of OCT as a new diagnostic marker for idiopathic normal pressure hydrocephalus, reporting, however, that non-shunted idiopathic normal pressure hydrocephalus patients showed choroidal thinning in combination with normal RNFL values.
Rizzo et al. [24] showed that CSF shunting resulted in significant improvement in average retinal nerve fiber layer (RNFL) thickness measurements by optical coherence tomography, which decreased by 87.27 ± 16.65 microns (p < 0.0001), and Frisen papilledema grades, which decreased by 2.19 ± 0.71 (p < 0.0001). From the present data analysis, it was determiend that both surgical procedures (VPS and ETV) were able to decrease the severity of papilledema post-operatively. From this study, it appears that there is no superiority of choice to any surgical procedure in these patients with obstructive hydrocephalus in the early post-operative period. Similarly, Swanson et al. [31] determined that intracranial pressure correlated with maximal retinal nerve fiber layer thickness (p ≤ 0.001), maximal retinal thickness (p ≤ 0.001), and maximal anterior retinal projection (p = 0.003), as the length of vertical line from the maximal internal limiting membrane elevation to the margins of the peripapillary Bruch’s membrane. An attractive attribute of OCT as a surrogate measure of ICP is its repeatability over time [32,33,34]. OCT-derived measures of optic nerve head volume may be more sensitive to papilledema improvement than the Frisen scale for the purposes of monitoring the treatment of ICP [35]. True papilledema secondary to increased ICP is expected to fluctuate with ICP. The longitudinal behavior and variability of the OCT parameters and specific metrics may be less prone to anatomic variations; it holds promise as a potential discriminator between true papilledema and pseudopapilledema (defined as anomalous elevation of one or both optic discs without edema of the retinal nerve fiber layer) [36] and warrants future study [31,32].
Our study has several limitations. First of all, the present study presented a very small number of patients and represents a single-institution experience. Second, the heterogeneity of the patient population and the short follow-up (7 days), due to the fact that most of these patients requires tumor removal surgery as soon as possible, inevitably added another layer of selection bias. Multicenter and randomized studies are needed to better understand the CSF dynamics of these patients. The use of virtual reality and new technologies in neurosurgery, which is spreading more and more in neurosurgery [37,38,39,40,41], will probably help surgeons to better understand these CSF dynamics and the role of obstructive hydrocephalus in the development of papilledema.

5. Conclusions

The resolution of papilledema was analyzed both pre- and post-operatively by decrease in modified Frisen grading in fundoscopy and retinal nerve fiber layer thickness (RNFL), followed by non-invasive optical coherence tomography (OCT). According to this study, VPS and ETV were equally efficient in ameliorating papilledema in obstructive hydrocephalus. For this reason, both can be considered for this particular purpose, according to their own indications and contraindications, complications and single-center experience.

Author Contributions

Conceptualization, S.D. (Sukriti Das), M.A. and D.G.; methodology, S.D. (Sukriti Das) and N.M.; validation, S.D. (Sukriti Das), N.M., S.D. (Sharbari Dey) and B.C.; formal analysis, M.A., D.G. and A.C.S.; investigation, M.A., D.G. and A.H.K.; resources, M.A. and A.H.K.; data curation, A.C.S., D.G. and N.M.; writing—original draft preparation, S.D. (Sukriti Das), M.A., A.H.K. and S.D. (Sharbari Dey); writing—review and editing, N.M. and B.C.; supervision, S.D. (Sukriti Das), N.M. and B.C. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Dhaka Medical College Hospital, Dhaka, Bangladesh (protocol code: ERC-DMC/ECC/2019/390; date: 26 December 2019).

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We thank Federica Tataranni for her English revision.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hellwig, D.; Grotenhuis, J.A.; Tirakotai, W.; Riegel, T.; Schulte, D.M.; Bauer, B.L.; Bertalanffy, H. Endoscopic third ventriculostomy for obstructive hydrocephalus. Neurosurg. Rev. 2005, 28, 1–34. [Google Scholar] [CrossRef]
  2. Kulkarni, A.V.; Drake, J.M.; Kestle, J.R.W.; Mallucci, C.L.; Sgouros, S.; Constantini, S. Predicting who will benefit from endoscopic third ventriculostomy compared with shunt insertion in childhood hydrocephalus using the ETV Success Score. J. Neurosurg. Pediatr. 2010, 6, 310–315. [Google Scholar] [CrossRef]
  3. Ahmed, N.; Alam, S.; Taikul, K.M.; Islam, M.H.; Ahsan, M.A. Subependymal giant cell astrocytoma associated with hyperproteinorrhachia, presented with vp shunt malfunction: A rare clinical entity. J. Neurol. 2020, 10, 97–99. [Google Scholar] [CrossRef]
  4. Montemurro, N.; Indaimo, A.; Di Carlo, D.T.; Benedetto, N.; Perrini, P. Surgical treatment of long-standing overt ventriculomegaly in adults (LOVA): A comparative case series between ventriculoperitoneal shunt (VPS) and endoscopic third ventriculostomy (ETV). Int. J. Environ. Res. Public Health 2022, 19, 1926. [Google Scholar] [CrossRef]
  5. Corbett, J.J. Neuro-ophthalmologic complications of hydrocephalus and shunting procedures. Semin. Neurol. 1986, 6, 111–123. [Google Scholar] [CrossRef] [PubMed]
  6. Lizana, J.; Reinoso, C.M.D.; Aliaga, N.; Marani, W.; Montemurro, N. Bilateral central retinal artery occlusion: An exceptional complication after frontal parasagittal meningioma resection. Surg. Neurol. Int. 2021, 12, 397. [Google Scholar] [CrossRef] [PubMed]
  7. Rigi, M.; Almarzouqi, S.J.; Morgan, M.L.; Lee, A.G. Papilledema: Epidemiology, etiology, and clinical management. Eye Brain 2015, 17, 47–57. [Google Scholar]
  8. Petrohelos, M.A.; Henderson, J.W. The ocular findings of intracranial tumor. A study of 358 cases. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1950, 55, 89–98. [Google Scholar] [PubMed]
  9. Sihota, R.; Tandon, R. Diseases of the optic nerve. In Parsons’ Diseases of the Eye, 23rd ed.; Elsevier: New Delhi, India, 2019; pp. 328–352. [Google Scholar]
  10. Mizrachi, I.B.B.; Trobe, J.D.; Gebarski, S.S.; Garton, H.J.L. Papilledema in the assessment of ventriculomegaly. J. Neuroophthalmol. 2006, 26, 260–263. [Google Scholar] [CrossRef] [PubMed]
  11. Ahuja, S.; Anand, D.; Dutta, T.K.; Kumar, V.R.R.; Kar, S.S. Retinal nerve fiber layer thickness analysis in cases of papilledema using optical coherence tomography—A case control study. Clin. Neurol. Neurosurg. 2015, 136, 95–99. [Google Scholar] [CrossRef] [PubMed]
  12. Perrini, P.; Montemurro, N. Congenital absence of a cervical spine pedicle. Neurol India 2016, 64, 189–190. [Google Scholar] [CrossRef] [PubMed]
  13. Scott, C.J.; Kardon, R.H.; Lee, A.G.; Frisén, L.; Wall, M. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs. clinical expert assessment using a clinical staging scale. Arch. Ophthalmol. 2010, 12, 705–711. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Funnell, J.P.; Craven, C.L.; D’Antona, L.; Thompson, S.D.; Chari, A.; Thorne, L.; Watkins, L.D.; Toma, A.K. Intracranial pressure in patients with papilloedema. Acta Neurol. Scand. 2018, 138, 137–142. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Rebolleda, G.; Munoz-Negrete, F.J. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Investig. Ophthalmol. Vis. Sci. 2009, 50, 5197–5200. [Google Scholar] [CrossRef]
  16. Bowd, C.; Weinreb, R.N.; Williams, J.M.; Zangwill, L.M. The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. Arch. Ophthalmol. 2000, 118, 22–26. [Google Scholar] [CrossRef]
  17. Nazir, S.; O’Brien, M.; Qureshi, N.H.; Slape, L.; Green, T.J.; Phillips, P.H. Sensitivity of papilledema as a sign of shunt failure in children. J. AAPOS 2009, 13, 63–66. [Google Scholar] [CrossRef]
  18. Montemurro, N.; Murrone, D.; Romanelli, B.; Ierardi, A. Postoperative Textiloma Mimicking Intracranial Rebleeding in a Patient with Spontaneous Hemorrhage: Case Report and Review of the Literature. Case Rep. Neurol. 2020, 12, 7–12. [Google Scholar] [CrossRef]
  19. El-Ghandour, N.M.F. Endoscopic third ventriculostomy versus ventriculoperitoneal shunt in the treatment of obstructive hydrocephalus due to posterior fossa in children. Childs Nerv. Syst. 2011, 27, 117–126. [Google Scholar] [CrossRef]
  20. Nishiyama, K.; Mori, H.; Tanaka, R. Changes in cerebrospinal fluid hydrodynamics following endoscopic third ventriculostomy for shunt-dependent noncommunicating hydrocephalus. J. Neurosurg. 2003, 98, 1027–1031. [Google Scholar] [CrossRef]
  21. Schwartz, T.H.; Ho, B.; Prestigiacomo, C.J.; Bruce, J.N.; Feldstein, N.A.; Goodman, R.R. Ventricular volume following third ventriculostomy. J. Neurosurg. 1999, 91, 20–25. [Google Scholar] [CrossRef] [Green Version]
  22. Podoleanu, A.G. Optical coherence tomography. J. Microsc. 2012, 247, 209–219. [Google Scholar] [CrossRef] [Green Version]
  23. Chahlavi, A.; El-babaa, S.K.; Luciano, M.G. Adult-onset hydrocephalus. Neurosurg. Clin. N. Am. 2001, 12, 753–760. [Google Scholar] [CrossRef]
  24. Rizzo, J.L.; Lam, K.V.; Wall, M.; Wilson, M.D. Perimetry, Retinal Nerve Fiber Layer Thickness and Papilledema Grade After Cerebrospinal Fluid Shunting in Patients with Idiopathic Intracranial Hypertension. J. Neuroophthalmol. 2015, 35, 22–25. [Google Scholar] [CrossRef] [PubMed]
  25. Koktekir, E.; Koktekir, B.; Hakan, K.; Gedik, S.; Akdemir, G. Resolution of papilledema after endoscopic third ventriculostomy versus cerebrospinal fluid shunting in hydrocephalus: A comparative study. J. Neurosurg. 2014, 120, 1465–1470. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Montemurro, N.; Santoro, G.; Marani, W.; Petrella, G. Posttraumatic synchronous double acute epidural hematomas: Two craniotomies, single skin incision. Surg. Neurol. Int. 2020, 11, 435. [Google Scholar] [CrossRef]
  27. Corsalini, M.; Di Venere, D.; Sportelli, P.; Magazzino, D.; Ripa, C.; Cantatore, F.; Cagnetta, G.; De Rinaldis, C.; Montemurro, N.; De Giacomo, A.; et al. Evaluation of prosthetic quality and masticatory efficiency in patients with total removable prosthesis: Study of 12 cases. Oral Implantol. 2018, 11, 230–240. [Google Scholar]
  28. Carruth, B.P.; Bersani, T.A.; Hurley, P.E.; Ko, M.W. Visual improvement after optic nerve sheath decompression in a case of congenital hydrocephalus and persistent visual loss despite intracranial pressure correction via shunting. Ophthalmic Plast. Reconstr. Surg. 2010, 26, 297–298. [Google Scholar] [CrossRef]
  29. Chou, S.Y.; Digre, K.B. Neuro-ophthalmic complications of raised intracranial pressure, hydrocephalus, and shunt malfunction. Neurosurg. Clin. N. Am. 1999, 10, 587–608. [Google Scholar] [CrossRef]
  30. Afonso, J.M.; Falcão, M.; Schlichtenbrede, F.; Falcão-Reis, F.; Silva, S.E.; Schneider, T.M. Spectral Domain-Optical Coherence Tomography as a New Diagnostic Marker for Idiopathic Normal Pressure Hydrocephalus. Front. Neurol. 2017, 1, 172. [Google Scholar] [CrossRef] [Green Version]
  31. Swanson, J.W.; Aleman, T.S.; Xu, W.; Ying, G.-S.; Pan, W.; Liu, G.T.; Lang, S.-S.; Heuer, G.G.; Storm, P.B.; Bartlett, S.P.; et al. Evaluation of Optical Coherence Tomography to Detect Elevated Intracranial Pressure in Children. JAMA Ophthalmol. 2017, 135, 320–328. [Google Scholar] [CrossRef]
  32. People, I.K.; Muhlbauer, M.S.; Sanford, R.A.; Kirk, E. Results and complications of intracranial pressure monitoring in 303 children. Pediatr. Neurosurg. 1995, 23, 64–67. [Google Scholar] [CrossRef] [PubMed]
  33. Langfitt, T.W.; Weinstein, J.D.; Kassell, N.F.; Simeone, F.A. Transmission of Increased Intracranial Pressure. I. Within the Craniospinal Axis. J. Neurosurg. 1964, 21, 989–997. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Stockslager, M.A.; Samuels, B.C.; Allingham, R.R.; Klesmith, Z.A.; Schwaner, S.A.; Forest, C.R.; Ethier, C.R. System for Rapid, Precise Modulation of Intraocular Pressure, toward Minimally-Invasive In Vivo Measurement of Intracranial Pressure. PLoS ONE 2016, 15, e0147020. [Google Scholar] [CrossRef] [PubMed]
  35. Malhotra, K.; Padungkiatsagul, T.; Moss, H.E. Optical coherence tomography use in idiopathic intracranial hypertension. Ann. Eye Sci. 2020, 5, 7. [Google Scholar] [CrossRef]
  36. Hoyt, W.F.; Pont, M.E. Pseudopapilledema: Anomalous elevation of optic disk. Pitafalls in diagnosis and management. JAMA 1962, 21, 191–196. [Google Scholar] [CrossRef]
  37. Montemurro, N.; Condino, S.; Cattari, N.; D’Amato, R.; Ferrari, V.; Cutolo, F. Augmented Reality-Assisted Craniotomy for Parasagittal and Convexity En Plaque Meningiomas and Custom-Made Cranio-Plasty: A Preliminary Laboratory Report. Int. J. Environ. Res. Public Health 2021, 18, 9955. [Google Scholar] [CrossRef]
  38. Mishra, R.; Narayanan, K.; Umana, G.E.; Montemurro, N.; Chaurasia, B.; Deora, H. Virtual Reality in Neurosurgery: Beyond Neurosurgical Planning. Int. J. Environ. Res. Public Health 2022, 19, 1719. [Google Scholar] [CrossRef]
  39. Montemurro, N.; Scerrati, A.; Ricciardi, L.; Trevisi, G. The Exoscope in Neurosurgery: An Overview of the Current Literature of Intraoperative Use in Brain and Spine Surgery. J. Clin. Med. 2022, 11, 223. [Google Scholar] [CrossRef]
  40. Raabe, C.; Fichtner, J.; Beck, J.; Gralla, J.; Raabe, A. Revisiting the rules for freehand ventriculostomy: A virtual reality analysis. J. Neurosurg. 2018, 128, 1250–1257. [Google Scholar] [CrossRef]
  41. Finger, T.; Schaumann, A.; Schulz, M.; Thomale, U.W. Augmented reality in intraventricular neuroendoscopy. Acta Neurochir. 2017, 159, 1033–1041. [Google Scholar] [CrossRef]
Figure 1. Pre-operative (A) OCT (RNFL, right eye 121 µm, left eye 239 µm). Pre-operative right (B) and left (D) eyes fundus and post-operative right (C) and left (E) eyes fundus and OCT (RNFL, right eye 109 µm, left eye 97 µm) after VPS in patient no. 3.
Figure 1. Pre-operative (A) OCT (RNFL, right eye 121 µm, left eye 239 µm). Pre-operative right (B) and left (D) eyes fundus and post-operative right (C) and left (E) eyes fundus and OCT (RNFL, right eye 109 µm, left eye 97 µm) after VPS in patient no. 3.
Medicina 58 00281 g001
Figure 2. Pre-operative (A) OCT (RNFL, right eye 175 µm, left eye 212 µm). Pre-operative right (B) and left (D) eyes fundus and post-operative right (C) and left (E) eyes fundus and OCT (B) (RNFL, right eye 105 µm, left eye 107 µm) after ETV in patient no. 15.
Figure 2. Pre-operative (A) OCT (RNFL, right eye 175 µm, left eye 212 µm). Pre-operative right (B) and left (D) eyes fundus and post-operative right (C) and left (E) eyes fundus and OCT (B) (RNFL, right eye 105 µm, left eye 107 µm) after ETV in patient no. 15.
Medicina 58 00281 g002
Table 1. Modified Frisen grading of papilledema.
Table 1. Modified Frisen grading of papilledema.
Grade 1Grayish C-shaped halo surrounding the disc; sparing of the temporal disc margin; radial nerve fiber striation disruption.
Grade 2Halo becomes circumferential; nasal border elevation; no major vessel obscuration.
Grade 3Obscuration of at least one vessel leaving the disc; elevation of all borders; circumferential halo.
Grade 4Obscuration of a major vessel on the disc; complete elevation including the cup; circumferential halo.
Grade 5Obscuration of all vessels on the disc and leaving the disc; all features of Grade 4.
Table 2. Demographic data of study population.
Table 2. Demographic data of study population.
CategoriesSub-Categories Number (%)
AgeYearsGroup A (VPS)Group B (ETV)
18–243 (33.3%)3 (33.3%)
25–353 (33.3%)3 (33.3%)
36–503 (33.3%)3 (33.3%)
SexMale6 (66.7%)7 (77.8%)
Female3 (33.3%)2 (22.2%)
Etiology of obstructive hydrocephalusCPA tumor2 (22.2%)2 (22.2%)
Posterior fossa tumor3 (33.3%)1 (11.1%)
Aqueductal stenosis2 (22.2%)4 (44.4%)
Pineal tumor2 (22.2%)2 (22.2%)
Clinical presentationPapilledema9 (100%)9 (100%)
Headache9 (100%)9 (100%)
Vomiting6 (66.7%)5 (27.7%)
Gait disturbance4 (44.4%)2 (22.2%)
Hearing loss4 (44.4%)2 (22.2%)
CPA, cerebellopontine angle.
Table 3. Modified Frisen grading and RNFL thickness in both eyes before and after VPS (Group A) or ETV (Group B).
Table 3. Modified Frisen grading and RNFL thickness in both eyes before and after VPS (Group A) or ETV (Group B).
Case No.Surgical TreatmentPreop
Frisen
Rt
Preop
RNFL
Rt (µm)
Postop
Frisen
Rt
Postop
RNFL
Rt (µm)
Preop
Frisen
Lt
Preop
RNFL
Lt (µm)
Postop
Frisen
Lt
Postop
RNFL
Lt (µm)
RNFL Change
Rt (µm)
RNFL
Change
Lt (µm)
Frisen
Change
Rt
Frisen
Change
Lt
1.VPSGrade 5300 Grade 3197Grade 5300Grade 217610312423
2.VPSGrade 3151Grade 1105Grade 1124Grade 1107461720
3.VPSGrade 1121Grade 1109Grade 4239Grade 1971214203
4.VPSGrade 3180Grade 2171Grade 3199Grade 316593410
5.VPSGrade 199Grade 196Grade 3166Grade 111635002
6.VPSGrade 1116Grade 1102Grade 3176Grade 1106147002
7.VPSGrade 3175Grade 2154Grade 4212Grade 1125218713
8.VPSGrade 3165Grade 1119Grade 2165Grade 1119464621
9.VPSGrade 2132Grade 1103Grade 1120Grade 1107291310
10.ETVGrade 2107 Grade 190Grade 2103Grade 164173911
11.ETVGrade 4184Grade 2136Grade 3165Grade 2130483521
12.ETVGrade 3175Grade 2144Grade 4212Grade 1115319713
13.ETVGrade 3176Grade 1102Grade 2116Grade 192742421
14.ETVGrade 3175Grade 1104Grade 4215Grade 11027111313
15.ETVGrade 3175Grade 1105Grade 4212Grade 11077010523
16.ETVGrade 2149Grade 1103Grade 2143Grade 1107463611
17.ETVGrade 3178Grade 2148Grade 3172Grade 1112306012
18.ETVGrade 1107Grade 163Grade 1112Grade 168444400
ETV, endoscopic third ventriculostomy; RNLF, retinal nerve fiber layer; VPS, ventriculoperitoneal shunt.
Table 4. Change to RNFL thickness in Group A (VPS) and Group B (ETV).
Table 4. Change to RNFL thickness in Group A (VPS) and Group B (ETV).
Surgical TreatmentEyeRNFL Thickness
Mean ± SD (Micrometers)
p Value
Pre-OperativePost-Operative
VPSRight159.8 ± 59.4128.4 ± 36.30.016
VPSLeft189.0 ± 56.6124.2 ± 27.60.003
ETVRight158.4 ± 30.7110.5 ± 27.5<0.001
ETVLeft161.1 ± 45.299.6 ± 21.60.001
ETV, endoscopic third ventriculostomy; RNLF, retinal nerve fiber layer; VPS, ventriculoperitoneal shunt.
Table 5. Change to Frisen grading 7 days after VPS (Group A).
Table 5. Change to Frisen grading 7 days after VPS (Group A).
EyePre-Operative Frisen GradingPost-Operative Frisen GradingTotalSpearman Rhop Value
Grade 1Grade 2Grade 3
RightGrade 130030.7210.028
Grade 21001
Grade 32204
Grade 50011
LeftGrade 12002
Grade 21001
Grade 320130.3750.333
Grade 41102
Grade 50011
Table 6. Change of Frisen grading 7 days after ETV (Group B).
Table 6. Change of Frisen grading 7 days after ETV (Group B).
EyePre-Operative Frisen GradingPost-Operative Frisen GradingTotalSpearman Rhop Value
Grade 1Grade 2Grade 3
RightGrade 110010.60.13
Grade 22002
Grade 32215
Grade 40011
LeftGrade 11001
Grade 221030.71.0
Grade 31102
Grade 41113
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Das, S.; Montemurro, N.; Ashfaq, M.; Ghosh, D.; Sarker, A.C.; Khan, A.H.; Dey, S.; Chaurasia, B. Resolution of Papilledema Following Ventriculoperitoneal Shunt or Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus: A Pilot Study. Medicina 2022, 58, 281. https://doi.org/10.3390/medicina58020281

AMA Style

Das S, Montemurro N, Ashfaq M, Ghosh D, Sarker AC, Khan AH, Dey S, Chaurasia B. Resolution of Papilledema Following Ventriculoperitoneal Shunt or Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus: A Pilot Study. Medicina. 2022; 58(2):281. https://doi.org/10.3390/medicina58020281

Chicago/Turabian Style

Das, Sukriti, Nicola Montemurro, Musannah Ashfaq, Dipankar Ghosh, Asit Chandra Sarker, Akhlaque Hossain Khan, Sharbari Dey, and Bipin Chaurasia. 2022. "Resolution of Papilledema Following Ventriculoperitoneal Shunt or Endoscopic Third Ventriculostomy for Obstructive Hydrocephalus: A Pilot Study" Medicina 58, no. 2: 281. https://doi.org/10.3390/medicina58020281

Article Metrics

Back to TopTop